creased skin and mucosal integrity, decreased function of neutrophils, and the relative quantitative deficiency of protective maternal IgO to Candida) [I, 3] .
Candida albicans is frequently identified as a colonizing organism on skin and mucous membranes; however, when clinical infection does occur, species identification does not necessarily determine the infecting strain of C. albicans. It is possible for the same strain to exhibit multiple phenotypic morphologies [5] . Conversely, data from recent studies using DNA-based typing methods have demonstrated that phenotypically identical Candida from multiple sites in women may actually be genetically different [6, 7] . Since strain delineation emanates from the level of the genome, delineation requires the DNAbased techniques of modem molecular biology [8] .
Current molecular typing methods using restriction endonuclease analysis of genomic DNA (REAG) and electrophoretic karyotyping (EK) with pulsed-field electrophoresis offer optimal means of discriminating specific Candida strains. These methods appear, at present, to be among the most practical typing methods for both large-scale and small-scale epidemiologic studies [8] . To date, the application of molecular typing for helping to define the relationship between maternal and neonatal colonization has been limited [9] . The goal of this prospective study of mother-infant pairs was to identify unique strains of Candida colonizing selected mothers at delivery and their preterm offspring. An additional goal was to determine if there was any specific strain of Candida that predominated in colonized neonates in our NICU.
Materials and Methods

Study Population
Selected mothers admitted to the labor and delivery department at the University of Virginia Health Sciences Center (Charlottesville, VA) from May 1993 through May 1994 who were likely to deliver an infant of <30 weeks of gestational age whose birth weight was < 1,500 g were invited to participate in this study. Mothers were considered ineligible if they were unlikely to deliver in <24 hours from admission or were receiving oral or topical antifungal medication.
Cultures and Microbiology
After consent was obtained, crural, vaginal, rectal, and oral specimens for fungal cultures were obtained from the mothers immediately before delivery by means of Culturette swabs (Becton Dickinson Microbiology Systems, Cockeysville, MD). Crural, oral, rectal, and endotracheal (if the patient was intubated) specimens for fungal cultures were obtained from the infants at 24 hours of age and again at 1, 2, and 4 weeks of age.
The swabs were placed in Culturette transport medium (Becton Dickinson Microbiology Systems) and then were plated on brain-heart infusion agar supplemented with 10% sheep blood agar, gentamicin (50 jlg/mL), and chloramphenicol (50 jlg/ mL) and on Sabouraud dextrose agar. Fungal isolates were identified by a standard yeast identification system (API 20 C R System; Analytab Products, Plainview, NY). Isolates were stored at -70°C in sterile distilled water. For the single blood culture positive for C. albieans, 0.5 mL ofblood was inoculated into the BacT-Alert (Organon Teknika, Durham, NC).
Molecular Typing
Molecular typing of all isolates was accomplished by EK and REAG with the restriction enzyme 8ft I followed by pulsedfield gel electrophoresis. EK and REAG were performed by means of a contour-clamped homogeneous electric field system (CHEF-DR II; Bio-Rad, Richmond, CA) as described previously [10] [11] [12] .
Three observers analyzed EK and REAG photographic profiles of ethidium bromide-stained gels to detect similarities and differences in banding patterns. Isolates were considered different if any readily detectable bands did not match. To achieve maximum strain discrimination, the results of EK and REAG were combined to give a composite DNA type.
Antifungal Testing
Broth microdilution testing was performed according to the guidelines of the National Committee for Clinical Laboratory Standards proposed standard [13] [14] [15] . The MIC endpoints were read visually and were defined for flucytosine and fluconazole as the lowest concentration in which a prominent decrease in turbidity (MIC-2) was observed and for amphotericin B as the lowest concentration producing complete inhibition of growth (MIC-O) [13, 14] . Drug-free and yeast-free controls were included, and quality control was ensured by testing strains of Candida parapsilosis (ATCC [American Type Culture Collection] 22019) and Candida krusei (ATCC 6258) that are recommended for this purpose [13, IS] .
Results
The study included 19 mothers with 21 infants (two sets of twins). The 19 mothers represented 86% of all eligible mothers during the study period. Cultures of surface specimens from 12 (63%) of the 19 mothers and seven (33%) of the 21 infants were positive for Candida (table 1) .Twenty culturesofspecimens from the 12 mothers and 28 cultures of specimens from the seven infants yielded Candida species.The isolates included C. albicans (33), C. parapsilosis (14) , and C. krusei (1) .
A total of 21 isolates were recovered from the 12 colonized mothers. C. albieans was isolated from 3 crural cultures (16%), 5 oral cultures (26%), 4 rectal cultures (21%), and 5 vaginal cultures (26%). C. parapsilosis was recovered from the oral cavity of two mothers. C. krusei was isolated from one vaginal culture, and Rhodotorula rubra was isolated from one rectal culture.
A total of 28 isolates were recovered from the seven colonized infants. C.parapsilosis was recovered almost exclusively from the infants (12 [86%] of 14), whereas C. albicans was isolated from both mothers and infants. Both mother and infant were colonized with fungi in only four (19%) of 21 motherinfant pairs, and C. albicans was isolated from only three (14%) of 21 mother-infant pairs.
Most Candida isolates were susceptible to the commonly used antifungal agents amphotericin B, fluconazole, and flucytosine (table 1) . Isolates from two different patients (infant 2b and mother 9) were resistant to fluconazole (MIC, ;;364 jlgl mL), and isolates from three different patients (mother 18, mother 19, and infant 19) were resistant to flucytosine (MIC, ;;364 jlg/mL).
There were 19 specific DNA types (strains) identified among the 48 isolates (figures 1-3 and table 1). Thirty-three C. albieans isolates (from 16 patients) represented 10 DNA types, and 14 C. parapsilosis isolates (from five patients) represented eight DNA types.
DNA typing of C. albicans isolates demonstrated colonization by a single DNA type at all specimen sites in an individual. The same species colonizing mother-infant pairs were also the same DNA type. The same DNA type (2B) colonized two mother-infant pairs (pair 2 and pair 4); however, the isolates from mother-infant pair 2 were significantly more resistant to fluconazole than were those from mother-infant pair 4 (MIC, 256 vs. 0.25 jlg/mL, respectively). All other isolates of C. a/bieans represented DNA types that were unique to individuals or to mother-infant pairs (table I) .
C. parapsilosis accounted for 43% (12 of 28) of the isolates colonizing infants and only 10% (2 of 20) of the isolates colonizing mothers. Two infants (infants 10 and 12) were colonized with C. parapsilosis for ;;321 days. Infant 10 was colonized 1 2 3 4 5 6 7 8 9 10 S same strain as their mothers. Despite the fact that the same genotype of e. albieans (2B) colonized two mother-infant pairs, the isolates from mother-infant pair 2 differed from the isolates from mother-infant pair 4 by resistance to fluconazole and were subsequently shown to be different based on preliminary work done by a PCR-based typing method (M . A. Pfaller, unpublished data).
Second, in this study, e. parapsilosis was found to colonize infants and could not be accounted for by a maternal reservoir. The possibility of an external or environmental reservoir for e. parapsilosis is suggested by colonization with more than one strain and by colonization with the same strain in two individuals (table 1) . e. parapsilosis is the most common species of Candida found on the hands of health care providers (M . A. Pfaller et aI., unpublished data and [16] ) and frequently colonizes infants in NICUs [17] . Introduction of'C, parapsilosis from an exogenous source (e.g., hands) to a microbiologically naive infant could explain the pattern of colonization (multiple strains) and probable cross-infection observed. Finally, although most isolates in this study were susceptible to commonly used antifungal agents, the detection of strains resistant to azoles or flucytosine is notable. The combination of amphotericin Band flucytosine has been recommended for the treatment of hematogenous candidiasis in the neonate [3, 4, 18] ; however, resistance to flucytosine may preclude its use for these patients.
An attack rate of 3%-4% has been previously described among neonates with invasive candidal infection in the NICU [2, 3] . We noted a similar attack rate for a single premature neonate (infant 4) who had systemic fungal disease due to C. albicans that was confirmed by positive cultures of blood and urine obtained at 8 days of age. The strain of C. albicans isolated from the blood had the same electrophoretic karyotype and restriction fragment digest pattern as the species isolated from the infant's skin and the infant's mother.
Conclusion
In this preliminary study using EK and REAG, we have shown that C. albicans can be vertically transmitted to premature high-risk neonates. In contrast, however, either C. parapsilos is is not as easily transmitted vertically as C. albicans or the maternal inoculum of C. parapsilosi s may be altered sufficiently in number or viability that subsequent growth is prevented because vaginal colonization in mothers was not observed. Finally, although most isolates in this study were susceptible to commonly used antifungal agents, the detection of strains resistant to azoles and flucytosine is remarkable and should help guide the use of antifungal therapy for infants with invasive fungal disease.
It may be that certain strains of Candida species are predisposed to colonizing pregnant women or that certain strains arc more likely to be vertically transmitted to high-risk neonates. If we are able to identify which strains of Candida species and specifically C. albicans are more likely to be vertically transmitted or cause systemic disease in neonates, then it may be reasonable to test the hypothesis that screening for fungal colonization in extremely premature infants could be beneficial in preventing subsequent serious fungal infections.
